These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Suppression of c-Myc and RRM2 expression in pancreatic cancer cells by the sphingosine kinase-2 inhibitor ABC294640. Lewis CS; Voelkel-Johnson C; Smith CD Oncotarget; 2016 Sep; 7(37):60181-60192. PubMed ID: 27517489 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of a UCMK/dCK fusion enzyme for gemcitabine-mediated cytotoxicity. Johnson AJ; Brown MN; Black ME Biochem Biophys Res Commun; 2011 Dec; 416(1-2):199-204. PubMed ID: 22093835 [TBL] [Abstract][Full Text] [Related]
30. Anti-cancer activity of gemcitabine against natural killer cell leukemia/lymphoma. Kim TM; Kim S; Ahn YO; Lee SH; Kim DW; Heo DS Leuk Lymphoma; 2014 Apr; 55(4):940-3. PubMed ID: 23772641 [No Abstract] [Full Text] [Related]
31. Identification of residues involved in the specificity and regulation of the highly efficient multisubstrate deoxyribonucleoside kinase from Drosophila melanogaster. Knecht W; Munch-Petersen B; Piskur J J Mol Biol; 2000 Aug; 301(4):827-37. PubMed ID: 10966789 [TBL] [Abstract][Full Text] [Related]
32. Nucleoside analogues: mechanisms of drug resistance and reversal strategies. Galmarini CM; Mackey JR; Dumontet C Leukemia; 2001 Jun; 15(6):875-90. PubMed ID: 11417472 [TBL] [Abstract][Full Text] [Related]
33. Effects of 2',2'-difluorodeoxycytidine (Gemcitabine) on wild type and variant mouse leukemia L1210 cells. Cory AH; Hertel LW; Kroin JS; Cory JG Oncol Res; 1993; 5(2):59-63. PubMed ID: 8364254 [TBL] [Abstract][Full Text] [Related]
34. Synthesis and biological activity of a gemcitabine phosphoramidate prodrug. Wu W; Sigmond J; Peters GJ; Borch RF J Med Chem; 2007 Jul; 50(15):3743-6. PubMed ID: 17602464 [TBL] [Abstract][Full Text] [Related]
35. The multisubstrate deoxyribonucleoside kinase of Drosophila melanogaster as a therapeutic suicide gene of breast cancer cells. Ma S; Zhao L; Zhu Z; Liu Q; Xu H; Johansson M; Karlsson A; Zheng X J Gene Med; 2011 Jun; 13(6):305-11. PubMed ID: 21674733 [TBL] [Abstract][Full Text] [Related]
36. RNA interference demonstrates a novel role for integrin-linked kinase as a determinant of pancreatic adenocarcinoma cell gemcitabine chemoresistance. Duxbury MS; Ito H; Benoit E; Waseem T; Ashley SW; Whang EE Clin Cancer Res; 2005 May; 11(9):3433-8. PubMed ID: 15867245 [TBL] [Abstract][Full Text] [Related]
37. Defective hCNT1 transport contributes to gemcitabine chemoresistance in ovarian cancer subtypes: overcoming transport defects using a nanoparticle approach. Hung SW; Marrache S; Cummins S; Bhutia YD; Mody H; Hooks SB; Dhar S; Govindarajan R Cancer Lett; 2015 Apr; 359(2):233-40. PubMed ID: 25600708 [TBL] [Abstract][Full Text] [Related]